1. Home
  2. CTOR vs KNDI Comparison

CTOR vs KNDI Comparison

Compare CTOR & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • KNDI
  • Stock Information
  • Founded
  • CTOR 2021
  • KNDI 2002
  • Country
  • CTOR United States
  • KNDI China
  • Employees
  • CTOR N/A
  • KNDI N/A
  • Industry
  • CTOR
  • KNDI Auto Manufacturing
  • Sector
  • CTOR
  • KNDI Consumer Discretionary
  • Exchange
  • CTOR NYSE
  • KNDI Nasdaq
  • Market Cap
  • CTOR 63.7M
  • KNDI 96.3M
  • IPO Year
  • CTOR N/A
  • KNDI N/A
  • Fundamental
  • Price
  • CTOR $5.30
  • KNDI $1.13
  • Analyst Decision
  • CTOR Buy
  • KNDI
  • Analyst Count
  • CTOR 2
  • KNDI 0
  • Target Price
  • CTOR $6.00
  • KNDI N/A
  • AVG Volume (30 Days)
  • CTOR 3.3M
  • KNDI 97.2K
  • Earning Date
  • CTOR 08-11-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • CTOR N/A
  • KNDI N/A
  • EPS Growth
  • CTOR N/A
  • KNDI N/A
  • EPS
  • CTOR N/A
  • KNDI N/A
  • Revenue
  • CTOR N/A
  • KNDI $127,569,613.00
  • Revenue This Year
  • CTOR N/A
  • KNDI N/A
  • Revenue Next Year
  • CTOR N/A
  • KNDI N/A
  • P/E Ratio
  • CTOR N/A
  • KNDI N/A
  • Revenue Growth
  • CTOR N/A
  • KNDI 3.21
  • 52 Week Low
  • CTOR $0.55
  • KNDI $0.89
  • 52 Week High
  • CTOR $49.00
  • KNDI $2.12
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • KNDI 51.22
  • Support Level
  • CTOR N/A
  • KNDI $1.06
  • Resistance Level
  • CTOR N/A
  • KNDI $1.16
  • Average True Range (ATR)
  • CTOR 0.00
  • KNDI 0.07
  • MACD
  • CTOR 0.00
  • KNDI 0.00
  • Stochastic Oscillator
  • CTOR 0.00
  • KNDI 57.14

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: